Toronto Cardiac Tumour Conference

 

Toronto Cardiac Tumour Conference
V

Neoadjuvant Chemotherapy: Evidence, Rationale and Approach. Is Combination Chemotherapy preferred over Single Agent Chemo? Is a Combination of Adriamycin and Ifosfamide the Preffered First Line Agent?

By Toronto Cardiac Tumour Conference FEATURING Vinod Ravi
By Toronto Cardiac Tumour Conference FEATURING Vinod Ravi
36 views
September 3, 2020
Comments 0
Login to view comments. Click here to Login
2020
38:29

Discussion: Undifferentiated Spindle Cell Neoplasm Treatment Options…

Toronto Cardiac Tumour Conference

A. Abdul, A. Mashari, B. Van Tine, K. Jawad, R. Cusimano, A. Gupta, M. Farkouh, D. Schultz

21 views
04:12

Case Presentation: Undifferentiated Spindle Cell Neoplasm Treated wi…

Toronto Cardiac Tumour Conference

K. Jawad

16 views
05:20

Case Presentation: Angiosarcoma Grade 3/3 with Mediastinal Lymphaden…

Toronto Cardiac Tumour Conference

G. Watson

18 views
13:36

Canadian Sarcoma Database (CanSARCC): Is There a Value in Creating a…

Toronto Cardiac Tumour Conference

A. Gupta

21 views
34:39

Discussion: Angiosarcoma Grade 3/3 with Mediastinal Lymphadenopathy …

Toronto Cardiac Tumour Conference

A. Abdul, D. Schultz, A. Mashari, B. Van Tine, G. Watson, A. Gupta, R. Cusimano, M. Farkouh

24 views
17:41

Panel Discussion: Canadian Sarcoma Database (CanSARCC): How Can It B…

Toronto Cardiac Tumour Conference

A. Gupta

14 views
23:27

Panel Discussion: The Importance of Starting a Cardiac Tumor Registr…

Toronto Cardiac Tumour Conference

M. Farkouh, D. Schultz

14 views
46:19

Is There a Difference in Efficacy Between Doxorubicin Bolus and Infu…

Toronto Cardiac Tumour Conference

A. Mashari, R. Cusimano, K. Jawad, G. Watson, R. Jones

21 views
26:59

Neoadjuvant Chemotherapy: Evidence, Rationale and Approach. Is Combi…

Toronto Cardiac Tumour Conference

V. Ravi

36 views
31:22

Beyond Chemotherapy in Cardiac Sarcomas: What Histological Subtypes …

Toronto Cardiac Tumour Conference

R. Jones

15 views
13:50

Adjuvant Therapies for Cardiac Malignancies: How Rare Are Cardiac Tu…

Toronto Cardiac Tumour Conference

R. Cusimano

16 views
17:48

The Role of Radiotherapy in the Management of Cardiac Tumours: Which…

Toronto Cardiac Tumour Conference

D. Schultz

62 views
37:45

Sarcoma Metabolism: What Metabolic Biomarkers Do We Have and What Th…

Toronto Cardiac Tumour Conference

B. Van Tine

28 views
28:37

Patient-specific 3D Modeling of Cardiac Tumors: What Are the Basic C…

Toronto Cardiac Tumour Conference

A. Mashari

132 views
16:47

Adjuvant Therapies in Cardiac Sarcomas: What Shold Be the Standard o…

Toronto Cardiac Tumour Conference

A. Abdul

12 views